GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

LUNG · Dec 31, 2023

Pulmonx Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001127537-24-000024General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

54.23% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.18% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-54.77% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

24.38% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

73.90% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

-90.19% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

26.33% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

32.18% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20258/9 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
210.80%
Current
54.23%
Delta
-156.57%
Capex Intensity Decreased
Previous
2.78%
Current
1.18%
Delta
-1.61%
Cash Generation Decreased
Previous
-48.82%
Current
-54.77%
Delta
-5.94%
Inventory Pressure Decreased
Previous
91.30%
Current
24.38%
Delta
-66.92%
Margin Increased
Previous
73.74%
Current
73.90%
Delta
0.16%
Profitability Decreased
Previous
-85.90%
Current
-90.19%
Delta
-4.29%
R And D Intensity Increased
Previous
23.89%
Current
26.33%
Delta
2.44%
Sbc Intensity Decreased
Previous
33.98%
Current
32.18%
Delta
-1.79%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · LUNG Fundamental State →Transitioned To · LUNG CAPEX_INTENSITY_DECREASED →Transitioned To · LUNG CASH_GENERATION_DECREASED →Transitioned To · LUNG Fundamental State →Transitioned To · LUNG BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · LUNG INVENTORY_PRESSURE_DECREASED →Transitioned To · LUNG MARGIN_INCREASED →Transitioned To · LUNG PROFITABILITY_DECREASED →Transitioned To · LUNG R_AND_D_INTENSITY_INCREASED →Transitioned To · LUNG SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.